117 related articles for article (PubMed ID: 8029286)
1. The effects of haloperidol, scopolamine, and MK-801 on amphetamine-induced increases in ascorbic and uric acid as determined by voltammetry in vivo.
Saponjic RM; Mueller K; Krug D; Kunko PM
Pharmacol Biochem Behav; 1994 May; 48(1):161-8. PubMed ID: 8029286
[TBL] [Abstract][Full Text] [Related]
2. Effects of haloperidol on amphetamine-induced increases in ascorbic acid and uric acid as determined by voltammetry in vivo.
Mueller K; Haskett C
Pharmacol Biochem Behav; 1987 Jun; 27(2):231-4. PubMed ID: 3628437
[TBL] [Abstract][Full Text] [Related]
3. The effects of haloperidol and amphetamine on ascorbic acid and uric acid in caudate and nucleus accumbens of rats as measured by voltammetry in vivo.
Mueller K
Life Sci; 1990; 47(8):735-42. PubMed ID: 2402194
[TBL] [Abstract][Full Text] [Related]
4. Acute treatment with the N-methyl-D-aspartate receptor antagonist MK-801: effect of concurrent administration of haloperidol or scopolamine on preproenkephalin mRNA levels of the striatum and nucleus accumbens of the rat brain.
Noailles PA; Villegas M; Ledoux M; Lucas LR; McEwen BS; Angulo JA
Neurosci Lett; 1996 Jan; 202(3):165-68. PubMed ID: 8848257
[TBL] [Abstract][Full Text] [Related]
5. Dopaminergic basis for the facilitation of brain stimulation reward by the NMDA receptor antagonist, MK-801.
Olds ME
Eur J Pharmacol; 1996 Jun; 306(1-3):23-32. PubMed ID: 8813611
[TBL] [Abstract][Full Text] [Related]
6. Haloperidol and MK-801 block increases in striatal calmodulin resulting from repeated amphetamine treatment.
Gnegy ME; Hewlett GH; Pimputkar G
Brain Res; 1996 Sep; 734(1-2):35-42. PubMed ID: 8896805
[TBL] [Abstract][Full Text] [Related]
7. Repeated administration of high doses of amphetamine increases release of ascorbic acid in caudate but not nucleus accumbens.
Mueller K
Brain Res; 1989 Aug; 494(1):30-5. PubMed ID: 2765922
[TBL] [Abstract][Full Text] [Related]
8. On the mechanism of d-amphetamine-induced changes in glutamate, ascorbic acid and uric acid release in the striatum of freely moving rats.
Miele M; Mura MA; Enrico P; Esposito G; Serra PA; Migheli R; Zangani D; Miele E; Desole MS
Br J Pharmacol; 2000 Feb; 129(3):582-8. PubMed ID: 10711358
[TBL] [Abstract][Full Text] [Related]
9. Evidence for dissociable mechanisms of amphetamine- and stress-induced behavioral sensitization: effects of MK-801 and haloperidol pretreatment.
Tolliver BK; Ho LB; Reid MS; Berger SP
Psychopharmacology (Berl); 1996 Aug; 126(3):191-8. PubMed ID: 8876018
[TBL] [Abstract][Full Text] [Related]
10. Amphetamine, cocaine, and dizocilpine enhance performance on a lever-release, conditioned avoidance response task in rats.
White IM; Christensen JR; Flory GS; Miller DW; Rebec GV
Psychopharmacology (Berl); 1995 Apr; 118(3):324-31. PubMed ID: 7617826
[TBL] [Abstract][Full Text] [Related]
11. Cholinergic modulation of basal and amphetamine-induced dopamine release in rat medial prefrontal cortex and nucleus accumbens.
Ichikawa J; Chung YC; Li Z; Dai J; Meltzer HY
Brain Res; 2002 Dec; 958(1):176-84. PubMed ID: 12468043
[TBL] [Abstract][Full Text] [Related]
12. The effects of amphetamine and pilocarpine on the release of ascorbic and uric acid in several rat brain areas.
Mueller K; Kunko PM
Pharmacol Biochem Behav; 1990 Apr; 35(4):871-6. PubMed ID: 2345762
[TBL] [Abstract][Full Text] [Related]
13. A single exposure to restraint stress induces behavioral and neurochemical sensitization to stimulating effects of amphetamine: involvement of NMDA receptors.
Pacchioni AM; Gioino G; Assis A; Cancela LM
Ann N Y Acad Sci; 2002 Jun; 965():233-46. PubMed ID: 12105099
[TBL] [Abstract][Full Text] [Related]
14. Voltammetric evidence in vivo of cholinergic modulation of extracellular ascorbic acid and uric acid in rat striatum.
Mueller K
Brain Res; 1987 Apr; 408(1-2):313-6. PubMed ID: 3594221
[TBL] [Abstract][Full Text] [Related]
15. Inhibitory avoidance memory deficit induced by scopolamine: Interaction of cholinergic and glutamatergic systems in the ventral tegmental area.
Mahmoodi G; Ahmadi S; Pourmotabbed A; Oryan S; Zarrindast MR
Neurobiol Learn Mem; 2010 Jul; 94(1):83-90. PubMed ID: 20403448
[TBL] [Abstract][Full Text] [Related]
16. Locomotor activation induced by MK-801 in the rat: postsynaptic interactions with dopamine receptors in the ventral striatum.
Ouagazzal A; Nieoullon A; Amalric M
Eur J Pharmacol; 1994 Jan; 251(2-3):229-36. PubMed ID: 8149978
[TBL] [Abstract][Full Text] [Related]
17. MK-801 and amphetamine result in dissociable profiles of cognitive impairment in a rodent paired associates learning task with relevance for schizophrenia.
Talpos J; Aerts N; Waddell J; Steckler T
Psychopharmacology (Berl); 2015 Nov; 232(21-22):3911-20. PubMed ID: 25902874
[TBL] [Abstract][Full Text] [Related]
18. The behavioral effects of MK-801 injected into nucleus accumbens and caudate-putamen of rats.
al-Khatib I; Karadag HC; Ulugöl A
Pharmacol Biochem Behav; 1995 Dec; 52(4):723-30. PubMed ID: 8587911
[TBL] [Abstract][Full Text] [Related]
19. Comparison of brain metabolic activity patterns induced by ketamine, MK-801 and amphetamine in rats: support for NMDA receptor involvement in responses to subanesthetic dose of ketamine.
Duncan GE; Miyamoto S; Leipzig JN; Lieberman JA
Brain Res; 1999 Oct; 843(1-2):171-83. PubMed ID: 10528123
[TBL] [Abstract][Full Text] [Related]
20. Effects of U-50,488H on scopolamine-, mecamylamine- and dizocilpine-induced learning and memory impairment in rats.
Hiramatsu M; Murasawa H; Nabeshima T; Kameyama T
J Pharmacol Exp Ther; 1998 Mar; 284(3):858-67. PubMed ID: 9495843
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
